- Lobbying
- watson AND pharmaceuticals
Lobbying Arrangements Results for 'Watson Pharmaceuticals'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029 |
WATSON PHARMACEUTICALS, INC
|
RUBICON ADVISORS, LLC | |||
Details Trade agreements, including the Trans-Pacific Partnership (TPP); the Transatlantic Trade and Investment Partnership (TTIP); Trade Promotion Authority (TPA); intellectual property and access to medi... |
Actavis, Inc (formerly Watson Pharmaceuticals, Inc.)
|
MFJ INTERNATIONAL | |||
Details Patent and settlements issues Medicare and Medicaid reimbursement for pharmaceuticals. Reimbursement for prostate cancer drugs. Prevention of preterm birth. junk fax regulations |
Watson Pharmaceuticals
|
STANTON PARK GROUP | |||
Details FDA regulation of boric acid suppositories. |
pH-D Feminine Health Systems
|
Squire Patton Boggs | |||
Details Abuse deterrent formulations Trans-Pacific Partnership (TPP) intellectual property protection and policy |
Allergan plc
|
Arent Fox LLP | |||
Details Proposals to enhance intellectual property protections to meet unmet medical needs, notably research and development of life-saving therapies; proposals to modify the Food Drug and Cosmetic Act whi... |
Allergan USA, Inc.
|
in-house lobbying | |||
Details Generic Drug Policy Issues |
Watson Pharmaceuticals
Pharmaceutical company involved in generic pharmaceutical products. |
Fierce, Isakowitz & Blalock | |||
Details Medicare Drug Reimbursement Policy Risk Evaluation and Mitigation Strategies, Tamper Resistant Formulations Junk Fax Prevention Act Implementation |
Watson Pharmaceuticals
|
FIERCE, ISAKOWITZ & BLALOCK |